{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:21:15Z","timestamp":1740126075463,"version":"3.37.3"},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Aldosterone has been recently characterized as a 'stress hormone'. Stress per se elicits a sizable rise in aldosterone secretion, which could be replicated by the administration of a low dose (0.03\u20131\u2009\u03bcg, IV) of adrenocorticotropic hormone (ACTH). Whether or not the aldosterone response to ACTH could be selectively impaired, that is, in association with intact cortisol response, is presently unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine whether or not the aldosterone response to low dose of ACTH is impaired in subjects referred to assess the hypothalamic\u2013pituitary\u2013adrenal axis (HPA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Outpatient referral endocrine day care centre.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>One hundred and ninety\u2010five consecutive subjects who underwent the low dose (1\u2009\u03bcg) ACTH test, in whom decreased cortisol reserve was suspected due to former\/present glucocorticoid excess, pituitary disease or\/and unexplained weakness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>The outcome was the detection of lack of aldosterone response, defined as a rise &lt;111\u2009pmol\/l.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In all, 46\/195 subjects had subnormal aldosterone response as compared with 52\/195 subjects showing diminished cortisol response. Nine subjects had combined deficient aldosterone and cortisol response. In the 37 subjects with isolated subnormal aldosterone response common associations were the use of exogenous glucocorticoids, mostly prednisone (<jats:italic>n<\/jats:italic>\u2009=\u200916); former Cushing disease (<jats:italic>n<\/jats:italic>\u2009=\u20092); nonfunctioning pituitary adenoma (<jats:italic>n<\/jats:italic>\u2009=\u20098); hypothyroidism (<jats:italic>n<\/jats:italic>\u2009=\u200911); the use of statins (<jats:italic>n<\/jats:italic>\u2009=\u200911), angiotensin\u2010converting enzyme inhibitors or angiotensin receptor blockers (<jats:italic>n<\/jats:italic>\u2009=\u20096), sex steroids in transgenders and orthostatic hypotension (<jats:italic>n<\/jats:italic>\u2009=\u20093). Twenty\u2010seven percent (25\/93) of the subjects with recent exposure to glucocorticoids had impaired aldosterone response to ACTH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Blunted aldosterone response to ACTH in the absence of hypoaldosteronism was seen in ~27% of subjects referred for HPA assessment using the low dose 1\u2009\u03bcg ACTH test. Exposure to glucocorticoid excess was often linked to this impairment, independent of the cortisol response to ACTH.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cen.14603","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T07:56:43Z","timestamp":1632988603000},"page":"513-520","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impaired aldosterone response to ACTH without hypoaldosteronism: An unrecognized secretory pattern in search of clinical implications"],"prefix":"10.1111","volume":"96","author":[{"given":"Yonit","family":"Marcus","sequence":"first","affiliation":[{"name":"Institute of Endocrinology, Metabolism and Hypertension Tel Aviv\u2010Sourasky Medical Center Tel Aviv Israel"},{"name":"The Sagol Center for Epigenetics of Aging and Metabolism Tel Aviv Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabi","family":"Shefer","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Metabolism and Hypertension Tel Aviv\u2010Sourasky Medical Center Tel Aviv Israel"},{"name":"The Sagol Center for Epigenetics of Aging and Metabolism Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-0539","authenticated-orcid":false,"given":"Karen","family":"Tordjman","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Metabolism and Hypertension Tel Aviv\u2010Sourasky Medical Center Tel Aviv Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Sofer","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Metabolism and Hypertension Tel Aviv\u2010Sourasky Medical Center Tel Aviv Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yona","family":"Greenman","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Metabolism and Hypertension Tel Aviv\u2010Sourasky Medical Center Tel Aviv Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5123-3176","authenticated-orcid":false,"given":"Naftali","family":"Stern","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Metabolism and Hypertension Tel Aviv\u2010Sourasky Medical Center Tel Aviv Israel"},{"name":"The Sagol Center for Epigenetics of Aging and Metabolism Tel Aviv Israel"},{"name":"Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-005-2343-3"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1530\/JME-15-0257"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.07.034"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(84)90225-5"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-80-6-693"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-5-1028"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb03392.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02037.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-1-186"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365513.2016.1268264"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(85)90517-4"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1268"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2014.08.014"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-6-1162"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00984.x"},{"issue":"4","key":"e_1_2_8_17_1","first-page":"1301","article-title":"The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases","volume":"80","author":"Tordjman K","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03041.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-36-1-30"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016759"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.14603","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cen.14603","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.14603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T05:04:19Z","timestamp":1693112659000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.14603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/cen.14603"],"URL":"https:\/\/doi.org\/10.1111\/cen.14603","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"type":"print","value":"0300-0664"},{"type":"electronic","value":"1365-2265"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"2021-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}